Skip to main content
IC
Fresenius SE & Co. KGaA (BIT:1FRE)
Italy flag Italy · Delayed Price · Currency is EUR
42.63
-0.16 (-0.37%)
At close: May 13, 2025, 5:30 PM CET

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Fresenius Kabi
Log In
Log In
Log In
Log In
Fresenius Kabi Growth
Log In
Log In
Log In
Log In
Fresenius Helios
Log In
Log In
Log In
Log In
Fresenius Helios Growth
Log In
Log In
Log In
Log In
Fresenius Medical Care
Log In
Log In
Log In
Log In
Fresenius Medical Care Growth
Log In
Log In
Log In
Log In
Fresenius Vamed
Log In
Log In
Log In
Log In
Fresenius Vamed Growth
Log In
Log In
Log In
Log In
Corporate
Log In
Log In
Log In
Log In
Corporate Growth
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
North America
Log In
Log In
Log In
Log In
North America Growth
Log In
Log In
Log In
Log In
Europe
Log In
Log In
Log In
Log In
Europe Growth
Log In
Log In
Log In
Log In
Asia-Pacific
Log In
Log In
Log In
Log In
Asia-Pacific Growth
Log In
Log In
Log In
Log In
Latin America
Log In
Log In
Log In
Log In
Latin America Growth
Log In
Log In
Log In
Log In
Africa
Log In
Log In
Log In
Log In
Africa Growth
Log In
Log In
Log In
Log In

Other

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Fresenius Kabi Operating Income
Log In
Log In
Log In
Log In
Fresenius Kabi Operating Income Growth
Log In
Log In
Log In
Log In
Fresenius Helios Operating Income
Log In
Log In
Log In
Log In
Fresenius Helios Operating Income Growth
Log In
Log In
Log In
Log In
Fresenius Medical Care Operating Income
Log In
Log In
Log In
Log In
Fresenius Medical Care Operating Income Growth
Log In
Log In
Log In
Log In
Fresenius Vamed Operating Income
Log In
Log In
Log In
Log In
Fresenius Vamed Operating Income Growth
Log In
Log In
Log In
Log In
Corporate Operating Income
Log In
Log In
Log In
Log In
Corporate Operating Income Growth
Log In
Log In
Log In
Log In
Helios Germany - Number of Hospitals
Log In
Log In
Log In
Log In
Helios Germany - Number of Hospitals Growth
Log In
Log In
Log In
Log In
Helios Germany - Number of Beds
Log In
Log In
Log In
Log In
Helios Germany - Number of Beds Growth
Log In
Log In
Log In
Log In
Helios Germany - Number of Hospital Patients
Log In
Log In
Log In
Log In
Helios Germany - Number of Hospital Patients Growth
Log In
Log In
Log In
Log In
Helios Germany - Number of Outpatient Patients
Log In
Log In
Log In
Log In
Helios Germany - Number of Outpatient Patients Growth
Log In
Log In
Log In
Log In
Fresenius Vamed - Order Intake
Log In
Log In
Log In
Log In
Fresenius Vamed - Order Intake Growth
Log In
Log In
Log In
Log In
Fresenius Vamed - Order Backlog
Log In
Log In
Log In
Log In
Fresenius Vamed - Order Backlog Growth
Log In
Log In
Log In
Log In
Organic Revenue Growth
Log In
Log In
Log In
Log In
Helios Germany - Total Number of Patient Admissions
Log In
Log In
Log In
Log In
Helios Germany - Total Number of Patient Admissions Growth
Log In
Log In
Log In
Log In
Helios Spain - Number of Hospitals
Log In
Log In
Log In
Log In
Helios Spain - Number of Hospitals Growth
Log In
Log In
Log In
Log In
Helios Spain - Number of Beds
Log In
Log In
Log In
Log In
Helios Spain - Number of Beds Growth
Log In
Log In
Log In
Log In
Helios Spain - Number of Hospital Patients
Log In
Log In
Log In
Log In
Helios Spain - Number of Hospital Patients Growth
Log In
Log In
Log In
Log In
Helios Spain - Number of Outpatient Patients
Log In
Log In
Log In
Log In
Helios Spain - Number of Outpatient Patients Growth
Log In
Log In
Log In
Log In
Helios Spain - Total Number of Patient Admissions
Log In
Log In
Log In
Log In
Helios Spain - Total Number of Patient Admissions Growth
Log In
Log In
Log In
Log In